BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2181419)

  • 1. Plasminogen activator activities in the ventral and dorsolateral prostatic lobes of aging Fischer 344 rats.
    Wilson MJ; Ditmanson JV; Sinha AA; Estensen RD
    Prostate; 1990; 16(2):147-61. PubMed ID: 2181419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aging and castration on plasminogen activator and metalloprotease activities in the rat prostate complex.
    Wilson MJ; Norris H; Woodson M; Sinha AA; Estensen RD
    Cell Mol Biol Res; 1995; 41(6):603-12. PubMed ID: 8777440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator activities in the developing rat prostate.
    Wilson MJ; Sinha AA; Powell JE; Estensen RD
    Biol Reprod; 1988 Apr; 38(3):723-31. PubMed ID: 3288284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of plasminogen activators during involution of the rat ventral prostate.
    Rennie PS; Bouffard R; Bruchovsky N; Cheng H
    Biochem J; 1984 Jul; 221(1):171-8. PubMed ID: 6431969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dietary supplementation with limonene or myo-inositol on the induction of neoplasia and matrix metalloproteinase and plasminogen activator activities in accessory sex organs of male Lobund-Wistar rats.
    Wilson MJ; Lindgren BR; Sinha AA
    Exp Mol Pathol; 2008 Oct; 85(2):83-9. PubMed ID: 18675799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator and metalloprotease activities of Du-145, PC-3, and 1-LN-PC-3-1A human prostate tumors grown in nude mice: correlation with tumor invasive behavior.
    Wilson MJ; Sinha AA
    Cell Mol Biol Res; 1993; 39(8):751-60. PubMed ID: 7951414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of amiloride on the urokinase plasminogen activators in prostatic cancer.
    Ray P; Bhatti R; Gadarowski J; Bell N; Nasruddin S
    Tumour Biol; 1998; 19(1):60-4. PubMed ID: 9422083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator activity in prostatic cancer.
    Köller A; Kirchheimer J; Pflüger H; Binder BR
    Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.
    Freeman SN; Rennie PS; Chao J; Lund LR; Andreasen PA
    Biochem J; 1990 Jul; 269(1):189-93. PubMed ID: 2115769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in the activities of antioxidant enzymes and lipid peroxidation status in ventral and dorsolateral prostate lobes of noble rats.
    Ghatak S; Ho SM
    Biochem Biophys Res Commun; 1996 May; 222(2):362-7. PubMed ID: 8670210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
    Wilson MJ; Sinha AA
    Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride selectively inhibits the urokinase-type plasminogen activator.
    Vassalli JD; Belin D
    FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of specific gelatinolytic proteinases in the lateral prostate of rats by ectopic pituitary grafts.
    Lee C; Sensibar JA; Sinha AA; Wilson MJ
    Biol Reprod; 1992 Apr; 46(4):671-9. PubMed ID: 1576265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal control of plasminogen activator secretion in organ culture of rat ventral prostate.
    Martikainen P; Suominen J; Vihko K
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):43-9. PubMed ID: 2643247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-related differences in plasminogen activator and plasminogen activator inhibiting activities in young and aged rats.
    Kojima T; Doi K; Kish M; Horiguchi Y
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):81-91. PubMed ID: 10604281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aging on growth factors gene and protein expression in the dorsal and ventral lobes of rat prostate.
    Zhao H; Patra A; Yeh CC; Tanaka Y; Oh BR; Dahiya R
    Biochem Biophys Res Commun; 2002 Mar; 292(2):482-91. PubMed ID: 11906188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal hypothyroidism alters the pattern of prostatic growth and differentiation, as well as plasminogen activator and metalloprotease expression, in the rat.
    Wilson MJ; Kirby JD; Zhao Y; Sinha AA; Cooke PS
    Biol Reprod; 1997 Feb; 56(2):475-82. PubMed ID: 9116149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic hyperplasia and neoplasia in aging F344 rats.
    Reznik G; Hamlin MH; Ward JM; Stinson SF
    Prostate; 1981; 2(3):261-8. PubMed ID: 6170967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.